Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of BR4002 (Donepezil Patch) vs Oral Donepezil in Healthy Volunteers
NCT04462029Phase 1Completed
- Sponsor
- Boryung
- Start
- Jun 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil transdermal patch in Alzheimer's disease (AD) (6 arms), sponsored by Boryung. Primary endpoints: Area Under the concentration-time Curve from time 0 to t and Maximum Observed Plasma Concentration. Started Jun 2020; status: completed.
02
Drugs
donepezil transdermal patch
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04462029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462029.